Dolph and Sharon von Arx have been philanthropic and service pillars of the Naples area for over thirty years.  Numerous organizations have benefitted from their generosity which in turn has enriched our community greatly.  Organizations and institutions fortunate to work closely alongside The von Arx Family are; the Naples Business Accelerator, Conservancy of Southwest Florida, Youth Haven, The Shelter for Abused Women and Children, NCH Healthcare Systems where Mr. von Arx served as Board Chair for 11 years, The Community Foundation, Hodges University, The Naples Museum of Art, and The Naples Philharmonic Center for the Arts just to name a few.  Dolph and Sharon have been in leadership positions in almost every organizations they have lent their names to and continually strive for the betterment of our area.  Serving as co-chairs of this Second Annual Naples Diabetes Conference has raised the bar of this conference’s goals to educate diabetes treatment, preventions, and research to the entire Naples Community; and help to further established it as an annual mainstay at the Greater Naples YMCA.


Michael Haller, MD is Chief of Pediatric Endocrinology at the University of Florida College of Medicine and has a passion for patient care, teaching, and research. Mike is a Gainesville native and a proud graduate of the University of Florida’s College of Medicine, Pediatrics Residency, and Pediatric Endocrinology Fellowship Programs.  In addition to serving as the Pediatric Endocrinology Fellowship director, Dr. Haller coordinates an active research team focused on the prediction, prevention, and reversal of type 1 diabetes.

Dr. Haller is an active investigator in the NIH funded Type 1 Diabetes TrialNet, the NIH TEDDY study, and the T1D Exchange. Mike serves as the Co-PI of the University of Florida TrialNet Clinical Center, as the Chair of the Clinical Implementation Committee for the TEDDY study, Vice-Chair for the T1DExchange Biobank, and as Vice-President of the Florida Camp for Children and Youth with Diabetes.   Dr. Haller was the PI of “first in man” studies aimed at using autologous umbilical cord blood stem cells as a potential therapy for type 1 diabetes and more recently led a groundbreaking pilot study demonstrating the efficacy of Thymogloublin and Neulasta in patients with established type 1 diabetes. Dr. Haller now serves as the PI of a major TrialNet study aimed at confirming the efficacy of Thymoglobulin and Neulasta in new-onset type 1 diabetes patients.  

SPEAKING TIMES: 12:05 - 12:45 - "T1D Research Update" Main Hall


Todd M. Brusko, Ph.D. is an associate professor within the Diabetes Institute at the University of Florida, College of Medicine. The research interests of his academic lab are centrally themed around understanding the mechanisms by which the immune system maintains a state of control, often referred to as immunological tolerance.  A portion of his lab is dedicated to understanding the basic genes controlling this process as well as identifying the defective immune checkpoints at play in individuals who develop autoimmune diseases including type 1 diabetes. Dr. Brusko has taken part in a number of prior and ongoing “first-in-man” clinical trials in T1D. These have included some of the first clinical uses of umbilical cord blood and regulatory T cells as a means to treat type 1 diabetes. In addition to these clinical efforts, much of his time is focused on large “team science” efforts, including participation in a NIH T1D program project grant, the Human Islet Research Network (HIRN), and network for Pancreatic Organ donors with Diabetes initiatives. 

SPEAKING TIMES: 1:10 - 1:50 "Harnessing the Immune System to Correct the Autoimmune Process that Initiates Type 1 Diabetes"  - Main Hall 


Jon Piganelli PhD  "Dr Piganelli is Associate Professor of Surgery, Immunology and Pathology Children’s Hospital of Pittsburgh at UPMC and has been involved in studying immunology and autoimmunity in Type 1 Diabetes. His work primarily focuses on the role of oxidative stress and free radical generation and how it leads to secondary inflammation since the majority pathological conditions have an inflammatory component. Also these redox reactions are critical for synergizing the innate and adaptive immune response, and exploitation of these reactions can modulate immune function. Dr. Piganelli has studied these interaction in both human islets isolated from cadaveric donors as well as in animal models of T1D like the NOD mouse. His work has demonstrated that modulation of redox dependent signaling can have positive effects on controlling aberrant immune responses as well as the protection and preservation of organs and tissue for transplantation."

SPEAKING TIMES:  11:20 - 11:55 "Families and T1D" Main Hall, 


Cayce Jehaimi, MD  is a Board Certified Pediatrician, Pediatric Endocrinologist & Physician Nutrition Specialist. He is a clinical staff member at Golisano Children's Hospital of Southwest Florida and Lee Physician Group with offices in Fort Myers, Naples and Port Charlotte. 

Dr. Jehaimi did his internship at the University of Alberta in Canada and residency at Tulane University in New Orleans, Louisiana, followed by a fellowship in Pediatric Endocrinology, Diabetes and Metabolism at the University of Texas Health Science Center in Houston, Texas. He welcomes any child, teenager or young adult with hormonal imbalances, thyroid, growth, pubertal or gender identity issues. 

SPEAKING TIMES:
2:40 - 3:15 "Type 2 Diabetes - What To Do To Reduce Your Child's Risk" - Main Hall 


Smiddy-labcoat-2016.jpg

William E. Smiddy, MD is a vitreoretinal specialist with the Bascom Palmer Eye Institute in Naples and is recognized not only in the local community, but nationally and internationally. Dr. Smiddy’s field of specialty, surgical treatment of retinal problems, includes conditions such as retinal detachments, complications of cataract surgery and diabetic retinopathy. His particular area of interest is surgical treatment of macular diseases such as epiretinal membranes and macular holes. His heavy clinical duties explain why the majority of his research efforts are at a clinical level.  In addition, he has studied and introduced numerous contributions to management of retinal complications of anterior segment surgery.  These include his having introduced an important and now established method of repositioning dislocated intraocular lenses.   Dr. Smiddy has been active in diabetic retinopathy clinical studies for more than two decades.

SPEAKING TIMES: 1:10 - 1:50 - "Taking Care of Your Eyes" - Breakout Room 1


Henry Rodriguez, MD is currently a Professor of Pediatrics at the University of South Florida (USF) in the Department of Pediatrics, Clinical Director of the USF Diabetes Center, and PI of the USF TrialNet Clinical Center. His career has focused on collaborative clinical research, clinical care, and education in type 1 diabetes. Dr. Rodriguez served as Principal Investigator and Clinical Center Director for the Type 1 Diabetes TrialNet Indiana University Clinical Center beginning at TrialNet’s inception in 2001 until his departure in 2010. He was recently awarded funding as PI and Director of the USF TrialNet Clinical Center. He has been an active member of the TrialNet in multiple capacities including Chair of the TrialNet Natural History Protocol Committee since 2010. He is also the PI for numerous diabetes clinical studies including the T1D Exchange USF Center and 9 industry sponsored trials investigating therapies in children and young adults with type 1 and type 2 diabetes.

SPEAKING TIMES: 1:00 - 1:50 - What is the TrialNet Pathway Study? -  Breakout Room 2
Dr. Rodriguez will also be available in the Weny Diabetes Center when he is not speaking to assist with the TrialNet Pathway Study


Danielle Henson, BSN, RN is a licensed Registered Nurse, who obtained her Bachelor of Science in Nursing with a minor in psychology from the University of South Florida. Since January 2011, she has helped develop a vast research department within the USF Diabetes Center.  As the lead nurse researcher and clinical research coordinator, she is dedicated to expanding knowledge about type 1 and type 2 diabetes to better help patients and their family members.  She is committed to the TrialNet Natural History Study of the Development of Type 1 Diabetes: A Pathway to Prevention study where her experience will help researchers gain knowledge to prevent type 1 diabetes and stop disease progression by preserving insulin production before and after diagnosis. 

 

TRIAL TIMES:
12:05 - 12:45 - "“TrialNet Pathway to Prevention Study” - Weny Diabetes Center
1:10 - 1:50 - “TrialNet Pathway to Prevention Study” - Weny Diabetes Center


David Baidal, MD is Assistant Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of Miami Miller School of Medicine. He is also a member of the Diabetes Research Institute's Clinical Islet Transplant Program. Dr. Baidal had completed his internal medicine residency at Jackson Memorial Hospital, University of Miami and was a part of the DRI's clinical transplant team, training under Drs. Rodolfo Alejandro and Camillo Ricordi. He then went on to complete a clinical and research fellowship at the Beth Israel Deaconess Medical Center / Joslin Diabetes Center in Boston. Following his fellowship, Dr. Baidal rejoined the DRI's Clinical Islet Transplant Program to focus on managing islet transplant recipients, developing new clinical islet transplant trials, and testing novel therapies for the treatment of type 1 diabetes.

SPEAKING TIMES:  3:15 - 3:55 - Closing Keynote on Islet Transplant Procedure - Main Hall

 


Wendy Peacock.jpg

Wendy Peacock, 44, was diagnosed with type 1 diabetes at 17 years old. She had diligently managed her blood sugar levels since her diagnosis, but began suffering with severe hypoglycemia unawareness a few years ago. A single mother with a 6-year-old son, John Paul, Wendy had to move in with her parents so they could help care for her. Desperate for a solution, she remembered seeing a news story about islet transplantation in 2002 and contacted the Diabetes Research Institute (DRI) to inquire about the procedure. Still producing some insulin, she was not a candidate for the trial but continued to follow the DRI’s progress. Wendy contacted the DRI again in 2014 after learning about the BioHub clinical trial and was selected as a candidate. She underwent the innovative procedure in August of 2015. Wendy, a contract manager for a government consulting firm, is the first patient to receive an infusion of islets within a biological scaffold engineered onto the omentum. She became insulin independent in record time following the transplant and remains free from insulin injections.

SPEAKING TIMES:  3:15 - 3:55 - Closing Keynote on Islet Transplant Procedure - Main Hall


Joshua Rednik is President and CEO of the Diabetes Research Institute Foundation.  Mr. Rednik served for nearly six years as Executive Director of The Jewish Community Foundation (JCF) of Greater MetroWest in Whippany, NJ.  Mr. Rednik came to the organization with 17 years of experience in the non-profit sector managing organizations and developing and executing multi-million dollar fundraising campaigns.  Mr. Rednik held senior leadership roles of increasing responsibility within the planned giving and endowment divisions of UJA-Federation of New York and The Jewish Federation of Greater Washington (Rockville, MD), where he began his career as Campaign Associate.  Mr. Rednik graduated from Washington University in St. Louis with a bachelor’s degree in psychology and pursued his master’s degree in social service at Bryn Mawr College, Bryn Mawr, PA. He received an executive certificate in financial planning from Georgetown University in Washington, D.C., and is a Certified Financial Planner™ professional. He resides in South Orange, NJ, with his wife and two children. 

SPEAKING TIMES:  3:15 - 3:55 - Closing Keynote on Islet Transplant Procedure - Main Hall 


Tom Headshot WEB.jpg

Tom Karlya, Vice President of the Diabetes Research Institute Foundation, is known throughout the diabetes community as Diabetes Dad.  He is the author/publisher of www.DiabetesDad.org,  which Healthline has named one of the top diabetes blogs for 2015 and 2016.   Tom has been introduced to the NY State Capitol, testified in Washington, D.C., and has lectured globally about being a DiabetesDad. He has been extremely active in a grassroots effort spreading awareness about the detection/understanding of type one diabetes (T1D), also the missing the diagnosis of T1D, and his positive attitude waiting for a biological cure. He has received numerous commendations for his work in the Diabetes Community from Hurricane Katrina to advocacy initiatives. Tom was awarded Advocate of the Year from The AADE and The Jeff Hitchcock Distinguished Service Award from CWD among many other awards from groups and organizations. For 12 years, as an actor, he starred in the New York Production of Tony 'N Tina's Wedding and also at The Kennedy Center, Washington, D.C., in Summer of the 17th Doll. His film, lbs., was at the Sundance Film Festival, and he appeared in Unsolved MysteriesSpin CityThe Cosby ShowNYPD BlueLaw and OrderAmerica's Most WantedEntertainment TonightAccess Hollywood, and numerous commercials. He won 13 Telly Awards, a FREDDIE Award, and was nominated for an Emmy Award while Executive Producer of dLife on CNBC. His mantra; just "Don't do Nothing", is well known throughout the diabetes community.

SPEAKING TIMES: 
2:00 - 2:30 - "Staying Positive" - Main Hall
2:40 - 3:15 - "Navigating Diabetes in a Social Media World" - Breakout Room 1 

Amy S. Chappell, M.D. - Dr. Chappell, aka "Dr. Amy", is a board certified neurologist with special competence in  child neurology. She graduated from Indiana University Medical School then completed 2 years of pediatrics and an epilepsy fellowship at the Johns Hopkins Medical Center after which she returned to Indiana and completed a neurology residency. She was on the full-time faculty in the neurology department of the Indiana University Medical Center until being hired as a clinical research physician by Eli Lilly and Company. She was the lead physician for the development of duloxetine for fibromyalgia which resulted in an FDA-approval. She re­tired from Lilly Research Laboratories in January 2014, after 25 years in clinical re­search. During her career at Lilly Dr. Chappell continued to practice neurology on a
volunteer basis as clinical associate professor at the Indiana University Medical Center. 

In 2014, pursuing a lifelong passion for wellness and physical exercise, Dr. Amy joined the American College of Lifestyle Medicine and became certified in The Complete Health Improvement Program (CHIP). She has facilitated 5 CHIP 3-month sessions at the Greater Naples YMCA and has seen tremendous and life-changing improvements in  those participants willing to take control of their health through nutrition, physical activity and stress management

SPEAKING TIMES: 
12:05 - 12:45 - The Impact of Lifestyle on Types 1, 2, 3 and Pre-diabetes - Kitchen / Conference Room
1:10 - 1:50 - The Impact of Lifestyle on Types 1, 2, 3 and Pre-diabetes - Kitchen / Conference Room


Eileen Christine Calerdon, Psy.D. - Dr. Calderon has over 10 years of extensive practical experience providing psychological services to diverse populations in a variety of settings.   She has worked with adults suffering from chronic mental health conditions, and has provided psychotherapy to children, adolescents, adults, families and couples in the context of a private practice. She currently works with Healthcare Network of Southwest Florida as a Psychologist providing mental and behavioral health services in team-based pediatric, adult, and family-oriented primary care settings.  She works to identify and modify behaviors to promote individuals’ health and wellness across their lifespan.

SPEAKING TIMES:  12:05 - 12:45 - Diabetes Overwhelmus - Breakout Room 2 


Amanda Vasquez is a licensed clinical social worker at the University of South Florida Diabetes Center. Amanda has a broad background is social work, with a specific emphasis on working with children and families affected by chronic illness to complete psychosocial assessments, identify needs and appropriate interventions, and to assist with advocacy, support and necessary resources.  She has worked extensively with children with type 1 diabetes and their families.  She is the current chair of the advocacy committee for the American Diabetes Association, to ensure that children with diabetes needs are being met while in school.  Amanda has worked directly with schools to ensure that individual medical management plans are received for each of the USF Diabetes Center patients, and works to ensure ongoing communication between the patient/family, diabetes medical home, schools and nursing providers to ensure that any needs or concerns are being adequately addressed. On this project, Amanda will serve on the Student Health Advisory Board to help inform the research plan and intervention.  She ensure ongoing communication between the diabetes medical home, patient/family and the school nursing team.

SPEAKING TIMES: 12:05 - 12:45 - "Transitioning Your Teen To College" Breakout Room 1


Sureka Bollepalli, MD is a Pediatric Endocrinologist at the University of South Florida, Diabetes Center. After completing her fellowship at Cincinnati Children’s Hospital, she joined the Department of Pediatrics at USF as Assistant Professor of Pediatrics. At the Diabetes Center, she is currently PI and co-PI of numerous studies related to type 1 and type 2 diabetes research, including, T1D Exchange,  TrialNet Natural History Study of the Development of Type 1 Diabetes: A Pathway to Prevention along with several intervention trials investigating new therapies for pediatric type 1 and type 2 diabetes. She has assisted in the development of the educational and clinical programs for type 1 and type 2 diabetes at the USF Diabetes Center. She participates in caring for children with type 1 diabetes at summer camps. Other work includes collaboration with the local school systems to improve diabetes care at school and evaluating psychological and physiological factors which influence disordered eating behavior in individuals with T1D. 

SPEAKING TIMES:    2:40 - 3:15 - "Understanding the Options: types of insulin, meters, pumps and more." -  Breakout Room 2